Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary …

R de Alarcon, B Alburquerque-Gonzalez… - Nephrology Dialysis …, 2022 - academic.oup.com
Secondary hyperparathyroidism (SHPT) is common in chronic kidney disease (CKD) and
dialysis patients, and results in renal osteodystrophy, thus causing the decreased synthesis …
被引用次数：3 相关文章

[引用][C] Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary …

R de Alarcón, B Alburquerque-González… - … : Official Publication of …, 2022 - europepmc.org
Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the
treatment response of dialysis patients with secondary hyperparathyroidism. - Abstract - Europe …

Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary …

R de Alarcón… - … publication of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the
treatment response of dialysis patients with secondary hyperparathyroidism Pharmacogenetic …

Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary …

R de Alarcón, B Alburquerque-González… - Nephrology Dialysis …, 2022 - academic.oup.com
Secondary hyperparathyroidism (SHPT) is common in chronic kidney disease (CKD) and
dialysis patients, and results in renal osteodystrophy, thus causing the decreased synthesis …